| SEC Info | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing As/For/On Docs:Pgs Issuer Agent 11/14/07 Fonix Corp 10-Q 9/30/07 5:83 Southridge Svcs LLC/FA
Document/Exhibit Description Pages Size
1: 10-Q Fonix Corporation Form 10-Q September 30, 2007 HTML 367K
2: EX-31.1 Certification of President HTML 11K
3: EX-31.2 Certification of Chief Financial Officer HTML 11K
4: EX-32.1 Certification of President Pursuant to Section 906 HTML 7K
of the Sarbanes-Oxley Act of 2002
5: EX-32.2 Certification of Chief Financial Officer Pursuant HTML 7K
to Section 906 of the Sarbanes-Oxley Act
of 2002
| fonix10q093007.htm |
|
[X]
|
Quarterly
Report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934 for the quarterly period ended September 30, 2007,
or
|
|
[ ]
|
Transition
Report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934 for the transition period from ______________ to
_____________.
|
|
22-2994719
|
|
|
(State
or other jurisdiction of incorporation or organization)
|
(I.R.S.
Employer Identification No.)
|
|
Page
|
||
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
|
3
|
||
|
Condensed
Consolidated Statements of Operations and Comprehensive Loss for
the Three
and Nine Months Ended September 30, 2007 and 2006
|
4
|
|
|
5
|
||
|
Notes
to Condensed Consolidated Financial Statements (Unaudited)
|
7
|
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
19
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
31
|
|
Item
4.
|
Controls
and Procedures
|
31
|
|
PART
II - OTHER INFORMATION
|
||
|
Item
1.
|
Legal
Proceedings
|
32
|
|
Item
1A.
|
Risk
Factors
|
33
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
34
|
|
Item
6.
|
Exhibits
|
34
|
|
September
30,
|
||||||||
|
|
2006
|
|||||||
|
ASSETS
|
||||||||
|
Current
assets
|
||||||||
|
Cash
and cash equivalents
|
$ |
13,000
|
$ |
5,000
|
||||
|
Prepaid
expenses and other current assets
|
2,000
|
4,000
|
||||||
|
Total
current assets
|
15,000
|
9,000
|
||||||
|
Property
and equipment, net of accumulated depreciation of $1,290,000 and
$1,261,000, respectively
|
19,000
|
48,000
|
||||||
|
Deposits
and other assets
|
117,000
|
117,000
|
||||||
|
Goodwill
|
2,631,000
|
2,631,000
|
||||||
|
Total
assets
|
$ |
2,782,000
|
$ |
2,805,000
|
||||
|
LIABILITIES
AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current
liabilities
|
||||||||
|
Accrued
liabilities
|
$ |
3,910,000
|
$ |
2,054,000
|
||||
|
Accounts
payable
|
1,375,000
|
1,504,000
|
||||||
|
Net
liabilities of discontinued subsidiaries
|
20,819,000
|
20,819,000
|
||||||
|
Derivative
liability
|
20,669,000
|
20,941,000
|
||||||
|
Accrued
payroll and other compensation
|
258,000
|
214,000
|
||||||
|
Accrued
settlement obligation
|
737,000
|
1,530,000
|
||||||
|
Deferred
revenues
|
446,000
|
460,000
|
||||||
|
Notes
payable - related parties
|
902,000
|
800,000
|
||||||
|
Series
E debentures
|
1,754,000
|
1,754,000
|
||||||
|
Advance
on Series N Preferred Stock
|
10,000
|
-
|
||||||
|
Current
portion of notes payable
|
3,512,000
|
2,883,000
|
||||||
|
Deposits
and other
|
7,000
|
7,000
|
||||||
|
Total
current liabilities
|
54,399,000
|
52,966,000
|
||||||
|
Long-term
notes payable, net of current portion
|
3,583,000
|
2,988,000
|
||||||
|
Total
liabilities
|
57,982,000
|
55,954,000
|
||||||
|
Commitments
and contingencies
|
||||||||
|
Stockholders'
deficit
|
||||||||
|
Preferred
stock, $0.0001 par value; 50,000,000 shares
authorized;
|
||||||||
|
Series
A, convertible; 166,667 shares outstanding (aggregate liquidation
preference of $6,055,000)
|
500,000
|
500,000
|
||||||
|
Common
stock, $0.0001 par value; 5,000,000,000 shares authorized;
|
||||||||
|
Class
A voting, 2,812,270,287 shares and 1,309,965,981 shares outstanding,
respectively
|
281,000
|
131,000
|
||||||
|
Class
B non-voting, none outstanding
|
-
|
-
|
||||||
|
Additional
paid-in capital
|
238,446,000
|
236,936,000
|
||||||
|
Outstanding
warrants to purchase Class A common stock
|
474,000
|
474,000
|
||||||
|
Cumulative
foreign currency translation adjustment
|
10,000
|
10,000
|
||||||
|
Accumulated
deficit
|
(294,911,000 | ) | (291,200,000 | ) | ||||
|
Total
stockholders' deficit
|
(55,200,000 | ) | (53,149,000 | ) | ||||
|
Total
liabilities and stockholders' deficit
|
$ |
2,782,000
|
$ |
2,805,000
|
||||
|
Three
Months Ended September 30,
|
Nine
Months Ended September 30,
|
|||||||||||||||
|
2006
|
2007
|
2006
|
||||||||||||||
|
Revenues
|
$ |
339,000
|
$ |
386,000
|
$ |
1,344,000
|
$ |
1,024,000
|
||||||||
|
Cost
of revenues
|
54,000
|
6,000
|
133,000
|
12,000
|
||||||||||||
|
Gross
profit
|
285,000
|
380,000
|
1,211,000
|
1,012,000
|
||||||||||||
|
Expenses:
|
||||||||||||||||
|
Selling,
general and administrative
|
502,000
|
2,024,000
|
1,966,000
|
4,444,000
|
||||||||||||
|
Product
development and research
|
338,000
|
551,000
|
1,263,000
|
1,711,000
|
||||||||||||
|
Total
expenses
|
840,000
|
2,575,000
|
3,229,000
|
6,155,000
|
||||||||||||
|
Other
income (expense):
|
||||||||||||||||
|
Interest
expense
|
(476,000 | ) | (528,000 | ) | (1,393,000 | ) | (1,279,000 | ) | ||||||||
|
Gain
on forgiveness of liabilities
|
199,000
|
199,000
|
||||||||||||||
|
Gain
(loss) on derivative liability
|
247,000
|
(1,763,000 | ) |
776,000
|
(1,763,000 | ) | ||||||||||
|
Other
income (expense), net
|
(30,000 | ) | (2,291,000 | ) | (418,000 | ) | (3,042,000 | ) | ||||||||
|
Net
loss from continuing operations
|
(585,000 | ) | (4,486,000 | ) | (2,436,000 | ) | (8,185,000 | ) | ||||||||
|
Net
loss from discontinued operations
|
-
|
(6,361,000 | ) |
-
|
(11,247,000 | ) | ||||||||||
|
Net
loss
|
(585,000 | ) | (10,847,000 | ) | (2,436,000 | ) | (19,432,000 | ) | ||||||||
|
Preferred
stock dividends
|
(436,000 | ) | (16,192,000 | ) | (1,278,000 | ) | (18,295,000 | ) | ||||||||
|
Loss
attributable to common stockholders
|
$ | (1,021,000 | ) | $ | (27,039,000 | ) | $ | (3,714,000 | ) | $ | (37,727,000 | ) | ||||
|
Basic
and diluted loss per common share from continuing
operations
|
$ | (0.00 | ) | $ | (0.03 | ) | $ | (0.00 | ) | $ | (0.04 | ) | ||||
|
Basic
and diluted loss per common share from discontinued
operations
|
$ | (0.00 | ) | $ | (0.01 | ) | $ | (0.00 | ) | $ | (0.02 | ) | ||||
|
Net
loss
|
$ | (585,000 | ) | $ | (10,847,000 | ) | $ | (2,436,000 | ) | $ | (19,432,000 | ) | ||||
|
Other
comprehensive (loss) income - foreign currency translation
|
-
|
-
|
-
|
7,000
|
||||||||||||
|
Comprehensive
loss
|
$ | (585,000 | ) | $ | (10,847,000 | ) | $ | (2,436,000 | ) | $ | (19,425,000 | ) | ||||
|
Nine
Months Ended September 30,
|
2006
|
|||||||
|
Cash
flows from operating activities
|
||||||||
|
Net
loss
|
$ | (2,436,000 | ) | $ | (19,432,000 | ) | ||
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||
|
Discontinued
operations
|
-
|
11,643,000
|
||||||
|
Gain
(loss) on derivative liability
|
(776,000 | ) |
1,763,000
|
|||||
|
Gain
on forgiveness of liabilities
|
(199,000 | ) |
-
|
|||||
|
Accretion
of discount on notes payable
|
774,000
|
603,000
|
||||||
|
Accretion
of discount on legal settlement
|
-
|
98,000
|
||||||
|
Write
down of intercompany receivable
|
-
|
|||||||